Loading
Total declarations
Company
▲ Purchases (23 ops.)
▼ Sales (0 ops.)
Latest filing published 20 Mar 2026 for Cumberland Pharmaceuticals INC, €4,368. Read the official filing
Filing timeline
BuySaleJames Jones
Insider track record
Disclosed buys
23
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
+20.2%
Across 16 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
James Jones: trading record in brief
This profile gathers the share dealings of James Jones in Cumberland Pharmaceuticals Inc, where the filings describe the role as board member. Over a trading history stretching from 17 March 2021 to 18 March 2026, the count stands at 43 filings.
Every open-market trade on record is a purchase: 23 purchases worth €1,666, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 7 share grants.
Half of the purchases are above €73 and half below. Clusters matter here: 23 out of 23 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.
Most recently, on 20 March 2026, the filings show a share grant worth €4,368 in Cumberland Pharmaceuticals Inc. The clock since the last published purchase (12 September 2025) now reads 401 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 34 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to James Jones
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations43 total
1,800 shares@ US$2.8018.3% of flowCommon StockSEC:0001087294-26-000039:0
18 shares@ US$2.360.2% of flowCommon StockSEC:0001087294-26-000006:0
13 shares@ US$2.800.1% of flowCommon StockSEC:0001490829-25-000007:0
13 shares@ US$3.310.2% of flowCommon StockSEC:0001490829-25-000005:0
12 shares@ US$3.540.2% of flowCommon StockSEC:0001087294-25-000008:0
13 shares@ US$3.440.2% of flowCommon StockSEC:0001628280-25-041987:0
Canonical exit: 30 Oct 2025 (T+90)
16 shares@ US$3.560.2% of flowCommon StockSEC:0001628280-25-039404:0
Canonical exit: 29 Sept 2025 (T+90)
8 shares@ US$5.200.2% of flowCommon StockSEC:0001628280-25-034816:0
Canonical exit: 31 Aug 2025 (T+90)
8 shares@ US$4.860.2% of flowCommon StockSEC:0001628280-25-029854:0
Canonical exit: 30 Jul 2025 (T+90)
8 shares@ US$4.240.1% of flowCommon StockSEC:0001628280-25-024353:0
Canonical exit: 30 Jun 2025 (T+90)
10 shares@ US$5.540.2% of flowCommon StockSEC:0001628280-25-016743:0
Canonical exit: 1 Jun 2025 (T+90)
1,000 shares@ US$5.1720.9% of flowCommon StockSEC:0001628280-25-013544:0
2,500 shares@ US$1.7117.4% of flowCommon StockSEC:0001628280-25-003184:0
70 shares@ US$1.330.4% of flowCommon StockSEC:0001628280-24-052608:0
Canonical exit: 2 Mar 2025 (T+90)
76 shares@ US$1.150.4% of flowCommon StockSEC:0001628280-24-050111:0
Canonical exit: 30 Jan 2025 (T+90)
62 shares@ US$1.270.3% of flowCommon StockSEC:0001628280-24-045331:0
Canonical exit: 30 Dec 2024 (T+90)
50 shares@ US$1.380.3% of flowCommon StockSEC:0001628280-24-042120:0
44 shares@ US$1.470.3% of flowCommon StockSEC:0001214659-24-016020:0
44 shares@ US$1.470.3% of flowCommon StockSEC:0001214659-24-013687:0
25 shares@ US$1.520.2% of flowCommon StockSEC:0001214659-24-011869:0
1,000 shares@ US$1.717.0% of flowCommon StockSEC:0001214659-24-005224:0
72 shares@ US$1.690.5% of flowCommon StockSEC:0001214659-23-017035:0
55 shares@ US$1.850.4% of flowCommon StockSEC:0001214659-23-016101:0
55 shares@ US$1.890.4% of flowCommon StockSEC:0001214659-23-014542:0
65 shares@ US$1.680.4% of flowCommon StockSEC:0001214659-23-013094:0
25 of 43 declarations
